109 related articles for article (PubMed ID: 16555997)
1. Cytochrome P450 1B1: a novel anticancer therapeutic target.
McFadyen MC; Murray GI
Future Oncol; 2005 Apr; 1(2):259-63. PubMed ID: 16555997
[TBL] [Abstract][Full Text] [Related]
2. Discovery of cytochrome P450 1B1 inhibitors as new promising anti-cancer agents.
Chun YJ; Kim S
Med Res Rev; 2003 Nov; 23(6):657-68. PubMed ID: 12939788
[TBL] [Abstract][Full Text] [Related]
3. Human CYP1B1 and anticancer agent metabolism: mechanism for tumor-specific drug inactivation?
Rochat B; Morsman JM; Murray GI; Figg WD; McLeod HL
J Pharmacol Exp Ther; 2001 Feb; 296(2):537-41. PubMed ID: 11160641
[TBL] [Abstract][Full Text] [Related]
4. Inhibitors and prodrugs targeting CYP1: a novel approach in cancer prevention and therapy.
Cui J; Li S
Curr Med Chem; 2014; 21(5):519-52. PubMed ID: 24083611
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenetics and regulation of human cytochrome P450 1B1: implications in hormone-mediated tumor metabolism and a novel target for therapeutic intervention.
Sissung TM; Price DK; Sparreboom A; Figg WD
Mol Cancer Res; 2006 Mar; 4(3):135-50. PubMed ID: 16547151
[TBL] [Abstract][Full Text] [Related]
6. Cytochrome P450 1B1: a target for inhibition in anticarcinogenesis strategies.
Peter Guengerich F; Chun YJ; Kim D; Gillam EM; Shimada T
Mutat Res; 2003; 523-524():173-82. PubMed ID: 12628515
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of cytochrome P450 1B1 in advanced non-small cell lung cancer: a potential therapeutic target.
Su JM; Lin P; Wang CK; Chang H
Anticancer Res; 2009 Feb; 29(2):509-15. PubMed ID: 19331196
[TBL] [Abstract][Full Text] [Related]
8. Cytochrome P450 1B1 is overexpressed and regulated by hypomethylation in prostate cancer.
Tokizane T; Shiina H; Igawa M; Enokida H; Urakami S; Kawakami T; Ogishima T; Okino ST; Li LC; Tanaka Y; Nonomura N; Okuyama A; Dahiya R
Clin Cancer Res; 2005 Aug; 11(16):5793-801. PubMed ID: 16115918
[TBL] [Abstract][Full Text] [Related]
9. Targeting cytochrome P450 CYP1B1 with a therapeutic cancer vaccine.
Luby TM
Expert Rev Vaccines; 2008 Sep; 7(7):995-1003. PubMed ID: 18767949
[TBL] [Abstract][Full Text] [Related]
10. Unexpected association between induction of immunity to the universal tumor antigen CYP1B1 and response to next therapy.
Gribben JG; Ryan DP; Boyajian R; Urban RG; Hedley ML; Beach K; Nealon P; Matulonis U; Campos S; Gilligan TD; Richardson PG; Marshall B; Neuberg D; Nadler LM
Clin Cancer Res; 2005 Jun; 11(12):4430-6. PubMed ID: 15958627
[TBL] [Abstract][Full Text] [Related]
11. Functional significance of cytochrome P450 1B1 in endometrial carcinogenesis.
Saini S; Hirata H; Majid S; Dahiya R
Cancer Res; 2009 Sep; 69(17):7038-45. PubMed ID: 19690133
[TBL] [Abstract][Full Text] [Related]
12. Regulation, function, and tissue-specific expression of cytochrome P450 CYP1B1.
Murray GI; Melvin WT; Greenlee WF; Burke MD
Annu Rev Pharmacol Toxicol; 2001; 41():297-316. PubMed ID: 11264459
[TBL] [Abstract][Full Text] [Related]
13. Novel methoxylated flavone inhibitors of cytochrome P450 1B1 in SCC-9 human oral cancer cells.
Walle T; Walle UK
J Pharm Pharmacol; 2007 Jun; 59(6):857-62. PubMed ID: 17637178
[TBL] [Abstract][Full Text] [Related]
14. Targeting drug-metabolizing enzymes for effective chemoprevention and chemotherapy.
Swanson HI; Njar VC; Yu Z; Castro DJ; Gonzalez FJ; Williams DE; Huang Y; Kong AN; Doloff JC; Ma J; Waxman DJ; Scott EE
Drug Metab Dispos; 2010 Apr; 38(4):539-44. PubMed ID: 20233842
[TBL] [Abstract][Full Text] [Related]
15. Development of an In Vitro Model to Screen CYP1B1-Targeted Anticancer Prodrugs.
Wang Z; Chen Y; Drbohlav LM; Wu JQ; Wang MZ
J Biomol Screen; 2016 Dec; 21(10):1090-1099. PubMed ID: 28139960
[TBL] [Abstract][Full Text] [Related]
16. Oxidation of xenobiotics by recombinant human cytochrome P450 1B1.
Shimada T; Gillam EM; Sutter TR; Strickland PT; Guengerich FP; Yamazaki H
Drug Metab Dispos; 1997 May; 25(5):617-22. PubMed ID: 9152602
[TBL] [Abstract][Full Text] [Related]
17. Cytochrome P450 1B1 expression in glial cell tumors: an immunotherapeutic target.
Barnett JA; Urbauer DL; Murray GI; Fuller GN; Heimberger AB
Clin Cancer Res; 2007 Jun; 13(12):3559-67. PubMed ID: 17575219
[TBL] [Abstract][Full Text] [Related]
18. Cytochrome P450 1B1 (CYP1B1) is overexpressed in human colon adenocarcinomas relative to normal colon: implications for drug development.
Gibson P; Gill JH; Khan PA; Seargent JM; Martin SW; Batman PA; Griffith J; Bradley C; Double JA; Bibby MC; Loadman PM
Mol Cancer Ther; 2003 Jun; 2(6):527-34. PubMed ID: 12813131
[TBL] [Abstract][Full Text] [Related]
19. Cytochromes P450 and cancer.
Kaminsky LS; Spivack SD
Mol Aspects Med; 1999; 20(1-2):70-84, 137. PubMed ID: 10575653
[No Abstract] [Full Text] [Related]
20. Effects of pomegranate chemical constituents/intestinal microbial metabolites on CYP1B1 in 22Rv1 prostate cancer cells.
Kasimsetty SG; Bialonska D; Reddy MK; Thornton C; Willett KL; Ferreira D
J Agric Food Chem; 2009 Nov; 57(22):10636-44. PubMed ID: 19919114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
